経皮ドラッグデリバリーシステムの世界市場規模調査・予測：技術別、用途別、地域別分析、2023年～2030年

世界の経皮ドラッグデリバリーシステム市場は、2022年に約591億6,000万米ドルと評価され、予測期間2023年～2030年には11.90％以上の成長率で成長すると予測されています。

経皮ドラッグデリバリーシステムは、皮膚から薬剤を投与する装置であり、薬剤を適用部位から直接血流に吸収させることができます。これらのシステムでは通常、薬剤を含むパッチや局所製剤が使用され、時間の経過とともに薬剤が徐々に放出されます。経皮デリバリーには、経口投与と比較して、薬物の徐放性、患者のコンプライアンス向上、消化管分解の回避、副作用リスクの低減など、いくつかの利点があります。経皮ドラッグデリバリーシステム市場が拡大している背景には、慢性疾患の罹患率の増加、老年人口の増加、経皮ドラッグデリバリーシステムの開発と使用を促進する政府の結束した取り組みなどの要因があります。

心血管疾患、糖尿病、疼痛関連疾患などの慢性疾患の有病率の増加は、経皮パッチが提供できる持続的かつ制御されたドラッグデリバリーへの需要を押し上げています。このように、慢性疾患の有病率の上昇が市場成長の原動力となっています。国際糖尿病連合は、2021年のインドの糖尿病患者数は7,419万4,700人と予想され、この数字は2030年までに9,297万3,700人に増加すると予測しています。さらに、ロバート・ウッド・ジョンソン財団の報告によると、米国では2020年に1億5,700万人の慢性疾患患者が発生し、2030年には1億7,100万人に増加すると予想されています。さらに、国際がん研究機関（IARC）は、2021年には190万人であった新規症例が、2040年には全世界で約2,750万人になると推定しています。また、研究開発の進展やヘルスケア産業への投資の増加が、市場成長に新たな機会をもたらす要因となっています。しかし、代替システムの利用可能性は、2023年～2030年の予測期間を通じて市場成長を阻害します。

世界の経皮ドラッグデリバリーシステム市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は2022年に最大の市場シェアで市場を独占しました。この地域の市場拡大は、主に特許切れによる新規企業の流入によって推進されています。さらに、以前は売れなかった医薬品の再ポジショニング、既存化合物の再製剤化、既存および新興市場参入企業の両方からの多額の投資が、この地域での大きな市場プレゼンスに顕著に寄与しています。アジア太平洋地域は、予測期間中に最も速いCAGRで大きく成長すると予想されます。この動向は、ヘルスケア支出の増加とヘルスケアインフラの迅速な進化に起因しています。さらに、中国やインドのような新興経済諸国では、研究開発への注目度が高まり、認知度が向上していることも拡大に拍車をかけています。

本調査の目的は、近年のさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の経皮ドラッグデリバリーシステム市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 業界の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 世界の経皮ドラッグデリバリーシステム市場力学

• 経皮ドラッグデリバリーシステム市場の影響分析（2020年～2030年）
  • 市場促進要因
    • 慢性疾患の増加
    • 高齢者人口の増加
    • 経皮ドラッグデリバリーシステムの開発と使用を促進する政府の取り組み
  • 市場の課題
    • 経皮ドラッグデリバリーシステムの高コスト
    • 規制上の課題
  • 市場機会
    • 継続的な研究開発活動
    • ヘルスケア産業への投資の増加

第4章 世界の経皮ドラッグデリバリーシステム市場の産業分析

• ポーターのファイブフォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターのファイブフォース影響分析
• PEST分析
  • 政治的
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 世界の経皮ドラッグデリバリーシステム市場：技術別

• 市場スナップショット
• 世界の経皮ドラッグデリバリーシステム市場：技術別、実績 - ポテンシャル分析
• 世界の経皮ドラッグデリバリーシステム市場：技術別、推定・予測（2020年～2030年）
• 経皮ドラッグデリバリーシステム市場：サブセグメント分析
  • エレクトロポレーション
  • ラジオ波
  • イオントフォレーシス
  • マイクロポレーション
  • サーマル
  • メカニカルアレイ
  • 超音波
  • その他

第6章 世界の経皮ドラッグデリバリーシステム市場：用途別

• 市場スナップショット
• 世界の経皮ドラッグデリバリーシステム市場：用途別、実績 - ポテンシャル分析
• 世界の経皮ドラッグデリバリーシステム市場：用途別、推定・予測（2020年～2030年）
• 経皮ドラッグデリバリーシステム市場：サブセグメント分析
  • 中枢神経系
  • 疼痛管理
  • 心血管
  • ホルモン
  • 免疫
  • 代謝
  • 消化器
  • 感染症
  • がん
  • その他

第7章 世界の経皮ドラッグデリバリーシステム市場：地域別分析

• 主要国
• 主な新興国
• 経皮ドラッグデリバリーシステム市場：地域別の市場スナップショット
• 北米
  • 米国
    • 技術別の推定・予測（2020年～2030年）
    • 用途別の推定・予測（2020年～2030年）
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他中東・アフリカ

第8章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Novartis AG
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
    • 最近の動向
  • Johnson & Johnson
  • Mylan Pharmaceuticals, Inc.
  • Boehringer Ingelheim GmbH
  • Hisamitsu Pharmaceutical co. Inc
  • 3M Company
  • Noven Pharmaceuticals, Inc.
  • 4P Therapeutics, LLC
  • Grunenthal GmbH
  • AbbVie Inc

第9章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性
• 調査前提条件

LIST OF TABLES

• TABLE 1. Global Transdermal Drug Delivery Systems Market, report scope
• TABLE 2. Global Transdermal Drug Delivery Systems Market estimates & forecasts by region 2020-2030 (USD Billion)
• TABLE 3. Global Transdermal Drug Delivery Systems Market estimates & forecasts by Technology 2020-2030 (USD Billion)
• TABLE 4. Global Transdermal Drug Delivery Systems Market estimates & forecasts by Application 2020-2030 (USD Billion)
• TABLE 5. Global Transdermal Drug Delivery Systems Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 6. Global Transdermal Drug Delivery Systems Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 7. Global Transdermal Drug Delivery Systems Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8. Global Transdermal Drug Delivery Systems Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9. Global Transdermal Drug Delivery Systems Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10. Global Transdermal Drug Delivery Systems Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11. Global Transdermal Drug Delivery Systems Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12. Global Transdermal Drug Delivery Systems Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13. Global Transdermal Drug Delivery Systems Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14. Global Transdermal Drug Delivery Systems Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15. U.S. Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16. U.S. Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 17. U.S. Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 18. Canada Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 19. Canada Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 20. Canada Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 21. UK Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 22. UK Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 23. UK Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 24. Germany Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 25. Germany Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 26. Germany Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 27. France Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 28. France Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 29. France Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 30. Italy Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 31. Italy Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 32. Italy Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 33. Spain Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 34. Spain Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 35. Spain Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 36. RoE Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 37. RoE Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 38. RoE Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 39. China Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 40. China Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 41. China Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 42. India Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 43. India Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 44. India Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 45. Japan Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 46. Japan Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 47. Japan Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 48. South Korea Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 49. South Korea Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 50. South Korea Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 51. Australia Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 52. Australia Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 53. Australia Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 54. RoAPAC Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 55. RoAPAC Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 56. RoAPAC Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 57. Brazil Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 58. Brazil Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 59. Brazil Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 60. Mexico Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 61. Mexico Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 62. Mexico Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 63. RoLA Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 64. RoLA Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 65. RoLA Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 66. Saudi Arabia Transdermal Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 67. South Africa Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 68. RoMEA Transdermal Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Transdermal Drug Delivery Systems Market
• TABLE 70. List of primary sources, used in the study of global Transdermal Drug Delivery Systems Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1. Global Transdermal Drug Delivery Systems Market, research methodology
• FIG 2. Global Transdermal Drug Delivery Systems Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Transdermal Drug Delivery Systems Market, key trends 2022
• FIG 5. Global Transdermal Drug Delivery Systems Market, growth prospects 2023-2030
• FIG 6. Global Transdermal Drug Delivery Systems Market, porters 5 force model
• FIG 7. Global Transdermal Drug Delivery Systems Market, pest analysis
• FIG 8. Global Transdermal Drug Delivery Systems Market, value chain analysis
• FIG 9. Global Transdermal Drug Delivery Systems Market by segment, 2020 & 2030 (USD Billion)
• FIG 10. Global Transdermal Drug Delivery Systems Market by segment, 2020 & 2030 (USD Billion)
• FIG 11. Global Transdermal Drug Delivery Systems Market by segment, 2020 & 2030 (USD Billion)
• FIG 12. Global Transdermal Drug Delivery Systems Market by segment, 2020 & 2030 (USD Billion)
• FIG 13. Global Transdermal Drug Delivery Systems Market by segment, 2020 & 2030 (USD Billion)
• FIG 14. Global Transdermal Drug Delivery Systems Market, regional snapshot 2020 & 2030
• FIG 15. North America Transdermal Drug Delivery Systems Market 2020 & 2030 (USD Billion)
• FIG 16. Europe Transdermal Drug Delivery Systems Market 2020 & 2030 (USD Billion)
• FIG 17. Asia pacific Transdermal Drug Delivery Systems Market 2020 & 2030 (USD Billion)
• FIG 18. Latin America Transdermal Drug Delivery Systems Market 2020 & 2030 (USD Billion)
• FIG 19. Middle East & Africa Transdermal Drug Delivery Systems Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Transdermal Drug Delivery Systems Market is valued approximately at USD 59.16 billion in 2022 and is anticipated to grow with a growth rate of more than 11.90% over the forecast period 2023-2030. Transdermal drug delivery systems are a devices for administering medications through the skin, allowing drugs to be absorbed into the bloodstream directly from the application site. These systems typically involve the use of patches or topical formulations containing the drug, which gradually releases the medication over time. Transdermal delivery offers several advantages, including sustained release of drugs, improved patient compliance, avoidance of gastrointestinal degradation, and reduced risk of side effects compared to oral administration. The Transdermal Drug Delivery Systems market is expanding because of factors such as increasing incidence of chronic diseases, growing Geriatric Population and cohesive government initiatives promoting the development and use of transdermal drug delivery systems.

The increasing prevalence of chronic conditions such as cardiovascular diseases, diabetes, and pain-related disorders has boosted the demand for sustained and controlled drug delivery, which transdermal patches can provide. Thus, rising prevalence of chronic disease is driving the market growth. The International Diabetes Federation stated that India has an anticipated 74,194.7 thousand cases of diabetes in 2021, and that figure is expected to increase to 92,973.7 thousand cases by 2030. Furthermore, the Robert Wood Johnson Foundation reports that there were 157 million cases of chronic illness in the United States in 2020, with an expected rise to 171 million cases by 2030. Furthermore, International Agency for Research on Cancer (IARC), estimated that by year 2040 there would be around 27.5 million new cases across the globe from 1.9 million new cases in year 2021. In addition, Ongoing research and development activities and rising investment in healthcare industry are some factors creating new opportunities to the market growth. However, availability of alternatives systems stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Transdermal Drug Delivery Systems Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share. The expansion of this region's market is primarily propelled by the expiration of patents, leading to an influx of new companies. Furthermore, the repositioning of previously unsuccessful drugs, the reformulation of existing compounds, and substantial investments from both established and emerging market participants have notably contributed to the significant market presence in this region. Asia Pacific is expected to grow significantly with fastest CAGR during the forecast period. This trend can be attributed to the increasing healthcare expenditure and the swift evolution of healthcare infrastructure. Furthermore, the expansion is fueled by the elevated focus on research and development and the rising awareness in emerging economies like China and India.

Major market player included in this report are:

• Novartis AG
• Johnson & Johnson
• Mylan Pharmaceuticals, Inc.
• Boehringer Ingelheim GmbH
• Hisamitsu Pharmaceutical co. Inc
• 3M Company
• Noven Pharmaceuticals, Inc.
• 4P Therapeutics, LLC
• Grunenthal GmbH
• AbbVie Inc

Recent Developments in the Market:

• In September 2023, Satio achieved a significant milestone in its journey with funding from ARPA-H. This investment underscores the company's focus on advancing SatioRx, a pioneering transdermal drug delivery device tailored for home use and remote management.
• In September 2022, Biomind Labs and Queen's University of Belfast obtained a controlled substances license, paving the way for the initiation of production for an innovative transdermal drug delivery system.

Global Transdermal Drug Delivery Systems Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Technology, Application, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:

• Electroporation
• Radio Frequency
• Iontophoresis
• Microporation
• Thermal
• Mechanical arrays
• Ultrasound
• Others

By Application:

• CNS
• Pain Management
• Cardiovascular
• Hormone
• Immunological
• Metabolic
• Gastrointestinal
• Infection
• Cancer
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Transdermal Drug Delivery Systems Market, by region, 2020-2030 (USD Billion)
  • 1.2.2. Transdermal Drug Delivery Systems Market, by Technology, 2020-2030 (USD Billion)
  • 1.2.3. Transdermal Drug Delivery Systems Market, by Application, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Transdermal Drug Delivery Systems Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Transdermal Drug Delivery Systems Market Dynamics

• 3.1. Transdermal Drug Delivery Systems Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidence of chronic diseases
    • 3.1.1.2. Growing geriatric population
    • 3.1.1.3. Government initiatives promoting the development and use of transdermal drug delivery systems
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Transdermal Drug Delivery Systems
    • 3.1.2.2. Regulatory Challenges
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Ongoing research and development activities
    • 3.1.3.2. Rising investment in healthcare industry

Chapter 4. Global Transdermal Drug Delivery Systems Market: Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economic
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Transdermal Drug Delivery Systems Market, by Technology

• 5.1. Market Snapshot
• 5.2. Global Transdermal Drug Delivery Systems Market by Technology, Performance - Potential Analysis
• 5.3. Global Transdermal Drug Delivery Systems Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
• 5.4. Transdermal Drug Delivery Systems Market, Sub Segment Analysis
  • 5.4.1. Electroporation
  • 5.4.2. Radio Frequency
  • 5.4.3. Iontophoresis
  • 5.4.4. Microporation
  • 5.4.5. Thermal
  • 5.4.6. Mechanical arrays
  • 5.4.7. Ultrasound
  • 5.4.8. Others

Chapter 6. Global Transdermal Drug Delivery Systems Market, by Application

• 6.1. Market Snapshot
• 6.2. Global Transdermal Drug Delivery Systems Market by Application, Performance - Potential Analysis
• 6.3. Global Transdermal Drug Delivery Systems Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4. Transdermal Drug Delivery Systems Market, Sub Segment Analysis
  • 6.4.1. CNS
  • 6.4.2. Pain Management
  • 6.4.3. Cardiovascular
  • 6.4.4. Hormone
  • 6.4.5. Immunological
  • 6.4.6. Metabolic
  • 6.4.7. Gastrointestinal
  • 6.4.8. Infection
  • 6.4.9. Cancer
  • 6.4.10. Others

Chapter 7. Global Transdermal Drug Delivery Systems Market, Regional Analysis

• 7.1. Top Leading Countries
• 7.2. Top Emerging Countries
• 7.3. Transdermal Drug Delivery Systems Market, Regional Market Snapshot
• 7.4. North America Transdermal Drug Delivery Systems Market
  • 7.4.1. U.S. Transdermal Drug Delivery Systems Market
    • 7.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
    • 7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
  • 7.4.2. Canada Transdermal Drug Delivery Systems Market
• 7.5. Europe Transdermal Drug Delivery Systems Market Snapshot
  • 7.5.1. U.K. Transdermal Drug Delivery Systems Market
  • 7.5.2. Germany Transdermal Drug Delivery Systems Market
  • 7.5.3. France Transdermal Drug Delivery Systems Market
  • 7.5.4. Spain Transdermal Drug Delivery Systems Market
  • 7.5.5. Italy Transdermal Drug Delivery Systems Market
  • 7.5.6. Rest of Europe Transdermal Drug Delivery Systems Market
• 7.6. Asia-Pacific Transdermal Drug Delivery Systems Market Snapshot
  • 7.6.1. China Transdermal Drug Delivery Systems Market
  • 7.6.2. India Transdermal Drug Delivery Systems Market
  • 7.6.3. Japan Transdermal Drug Delivery Systems Market
  • 7.6.4. Australia Transdermal Drug Delivery Systems Market
  • 7.6.5. South Korea Transdermal Drug Delivery Systems Market
  • 7.6.6. Rest of Asia Pacific Transdermal Drug Delivery Systems Market
• 7.7. Latin America Transdermal Drug Delivery Systems Market Snapshot
  • 7.7.1. Brazil Transdermal Drug Delivery Systems Market
  • 7.7.2. Mexico Transdermal Drug Delivery Systems Market
• 7.8. Middle East & Africa Transdermal Drug Delivery Systems Market
  • 7.8.1. Saudi Arabia Transdermal Drug Delivery Systems Market
  • 7.8.2. South Africa Transdermal Drug Delivery Systems Market
  • 7.8.3. Rest of Middle East & Africa Transdermal Drug Delivery Systems Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
  • 8.1.1. Company 1
  • 8.1.2. Company 2
  • 8.1.3. Company 3
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. Novartis AG
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Recent Developments
  • 8.3.2. Johnson & Johnson
  • 8.3.3. Mylan Pharmaceuticals, Inc.
  • 8.3.4. Boehringer Ingelheim GmbH
  • 8.3.5. Hisamitsu Pharmaceutical co. Inc
  • 8.3.6. 3M Company
  • 8.3.7. Noven Pharmaceuticals, Inc.
  • 8.3.8. 4P Therapeutics, LLC
  • 8.3.9. Grunenthal GmbH
  • 8.3.10. AbbVie Inc

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption